- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By Tom Fox2016-09-21T17:15:00
Tom Fox looks at Sir Andrew Witty’s career as chief executive of GlaxoSmithKline, as the CEO recently resigned and was replaced by Emma Walmsley.
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2020-01-30T21:47:00Z By Jaclyn Jaeger
The U.K. Competition and Markets Authority won a victory in a decision by Europe’s high court, ruling GlaxosmithKline’s entering of a financial deal with industry rivals to delay the generic version of its drugs violates EU competition law.
2018-02-13T06:30:00Z By Tom Fox
GlaxoSmithKline recently said U.S. enforcement agencies asked for information about third-party advisers the company hired in China during a corruption investigation in the country. The Man From FCPA asks, why now?
2016-11-22T10:30:00Z By Bill Coffin
If GlaxoSmithKline deserved a declination to prosecute, then the Justice Department needs to provide a better explanation as to why. Tom Fox reports.
Site powered by Webvision Cloud